Supplementary Data from miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
Xiaohua Li(Beijing University of Chinese Medicine), Fan Daiming, Zheyi Han, Yongzhang Nie(Xijing Hospital), Kaichun Wu(Xijing Hospital), Sun Li(Kobe University), Shuang Han(Jiangnan University), Ying Zhang(Jinan University), Yongquan Shi(National Clinical Research Center for Digestive Diseases), Jie Ding, Xiaonan Liu(Shanghai Jiao Tong University), Xiong Chen(Wenzhou Medical University), Gang Ji(Centre National de la Recherche Scientifique), Mengbin Li(Xijing Hospital), Qinchuan Zhao(Xijing Hospital), Hongwei Zhang(University of Massachusetts Chan Medical School), Taiqian Gong(Chinese PLA General Hospital)
Cited by 0
Related Papers
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
|Cell Death and Disease|2016|574
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
|bioRxiv (Cold Spring Harbor Laboratory)|2021|480
miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
|Molecular Cancer Research|2011|361